Unknown

Dataset Information

0

Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors.


ABSTRACT: Chimeric antigen receptor (CAR) T cell therapy has emerged as an attractive strategy for cancer immunotherapy. Despite remarkable success for hematological malignancies, excessive activity and poor control of CAR T cells can result in severe adverse events requiring control strategies to improve safety. This work illustrates the feasibility of a zinc finger-based inducible switch system for transcriptional regulation of an anti-CD20 CAR in primary T cells providing small molecule-inducible control over therapeutic functions. We demonstrate time- and dose-dependent induction of anti-CD20 CAR expression and function with metabolites of the clinically-approved drug tamoxifen, and the absence of background CAR activity in the non-induced state. Inducible CAR T cells executed fine-tuned cytolytic activity against target cells both in vitro and in vivo, whereas CAR-related functions were lost upon drug discontinuation. This zinc finger-based transcriptional control system can be extended to other therapeutically important CARs, thus paving the way for safer cellular therapies.

SUBMITTER: Kotter B 

PROVIDER: S-EPMC8507528 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2604467 | biostudies-literature
| S-EPMC7978433 | biostudies-literature
| S-EPMC9374162 | biostudies-literature
| S-EPMC1187960 | biostudies-literature
| S-EPMC3436144 | biostudies-literature
| S-EPMC4169156 | biostudies-literature
2022-06-30 | GSE163886 | GEO
| S-EPMC3625871 | biostudies-literature
| S-EPMC3650244 | biostudies-other
| S-EPMC1976285 | biostudies-literature